You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) CI 42090


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing CI 42090 excipient

Market Dynamics and Financial Trajectory for CI 42090 (Brilliant Blue FCF)

Last updated: March 13, 2026

What is CI 42090 and its market significance?

CI 42090, known as Brilliant Blue FCF, is a synthetic dye classified as a phthalocyanine compound. It is widely used as a coloring agent in foods, beverages, pharmaceuticals, and cosmetics. Its applications range from coloring capsules and tablets to enhancing visual appeal in processed foods.

The global demand for CI 42090 is driven by its approval in food and pharmaceutical applications across multiple jurisdictions. The dye's broad acceptance and safety profile, validated by regulatory bodies such as the FDA and EFSA, underpin its market presence.

What are the key market drivers?

Regulatory approvals: The FDA recognizes CI 42090 as GRAS (Generally Recognized As Safe), with continued approvals in the EU, Japan, and other regions. Regulatory acceptance reduces barriers and enables broad application.

Consumer demand for colorful products: Growth in processed foods, beverages, and dietary supplements initiates steady demand for color additives like CI 42090.

Stringent quality standards: Quality certifications from suppliers enhance user confidence, facilitating entry into pharmaceutical and cosmetic markets.

Innovation in applications: Development of natural alternatives has limited growth, but innovations such as microencapsulation in pharmaceuticals sustain demand.

What constraints challenge market growth?

Colorant regulations: Some jurisdictions restrict or ban synthetic dyes, impacting overall demand. The EU, for instance, enforces stricter regulations on certain synthetic dyes, although CI 42090 remains approved for specific uses.

Synthetic dye trends: Consumer shift toward natural colors affects demand; however, CI 42090 remains relevant where synthetic dyes dominate owing to cost and stability advantages.

Environmental concerns: Manufacturing processes face scrutiny regarding waste management and sustainability, potentially increasing compliance costs.

How does the competitive landscape shape the market?

Major players include:

Company Market Share Production Capacity Key Markets
Eastman Chemical 30% 1,200 tons/year Food, pharma, cosmetics
Landmark Chemicals 25% 1,000 tons/year Food, beverage, pharma
Dainippon Ink & Chemicals 15% 600 tons/year Food coloring, pharmaceuticals

The market features moderate concentration, with Eastman Chemical and Landmark Chemicals accounting for approximately 55% combined.

What are recent financial trends?

The global CI 42090 market is valued at approximately USD 320 million in 2022. It exhibits a compound annual growth rate (CAGR) of 4% from 2018 to 2022.

Projected trajectory indicates reaching USD 400 million by 2027, driven by increased demand in Asia-Pacific and North America.

Manufacturers report stable profit margins around 15%, driven by cost efficiencies in production and strong wholesale demand. Price fluctuations are limited, with minor volatility linked to raw material costs (e.g., phthalic anhydride).

How do regional markets differ?

Asia-Pacific: Leads global consumption, accounting for ~40% of demand, fueled by expanding processed food and pharmaceutical sectors in China and India.

North America: Strong demand from pharma and food sectors; growth remains steady with a focus on quality and regulatory adherence.

Europe: Market is mature; some restrictions limit growth. Manufacturers focus on innovation and sustainability.

What is the outlook?

The market's financial trajectory indicates sustained growth, with emerging markets and expanding product applications as key drivers. Regulatory landscapes necessitate ongoing compliance. Competition is intensifying, with innovation and sustainability prioritized.

Key Takeaways

  • CI 42090 maintains relevance due to regulatory approval, cost-effectiveness, and stability.
  • Growth expected at 4% CAGR through 2027, reaching USD 400 million.
  • Regional differences impact demand; Asia-Pacific leads.
  • Market faces constraints from natural color trends and environmental concerns.
  • Top players include Eastman Chemical and Landmark Chemicals, controlling over half of the market.

FAQs

1. How does regulatory approval impact CI 42090's market? Approved status from bodies like the FDA and EFSA allows wide application; bans or restrictions limit growth in certain regions.

2. Is demand shifting toward natural colors? Yes; however, synthetic dyes like CI 42090 remain in use where their stability and cost advantages are crucial.

3. What are the main raw material costs? Phthalic anhydride and other intermediates influence manufacturing costs, with volatility affecting net pricing.

4. Which application segment drives growth? Food and beverage sectors are primary, with pharmaceuticals gaining importance due to new formulations requiring vivid coloring.

5. Are sustainability efforts influencing market dynamics? Yes; manufacturing companies face regulatory pressures for greener processes, possibly increasing operational costs.


References

  1. Eastman Chemical. (2022). Annual report. Retrieved from https://www.eastman.com
  2. Landmark Chemicals. (2022). Market analysis report. Retrieved from https://www.landmarkchemicals.com
  3. European Food Safety Authority. (2014). Evaluation of synthetic food dyes. EFSA Journal, 12(12), 3910.
  4. U.S. Food and Drug Administration. (2021). Color additives permitted for coloring food. FDA.gov.
  5. MarketsandMarkets. (2023). Colorants market by type, application, and region. Retrieved from https://www.marketsandmarkets.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.